LexaGene Holdings Inc. Quarterly Common Stock, Value, Issued in USD from Q1 2022 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary
LexaGene Holdings Inc. quarterly Common Stock, Value, Issued history and growth rate from Q1 2022 to Q4 2022.
  • LexaGene Holdings Inc. Common Stock, Value, Issued for the quarter ending November 30, 2022 was $41.4M.
Common Stock, Value, Issued, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $41.4M Nov 30, 2022 10-Q 2023-01-17
Q3 2022 $40.7M Aug 31, 2022 10-Q 2022-10-18
Q1 2022 $40.4M Feb 28, 2022 10-Q 2023-01-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.